Core Viewpoint - MiMedx Group, Inc. will report its operating and financial results for Q4 and the full year ended December 31, 2025, on February 25, 2026, after market close [1] Group 1 - The senior management team will host a webcast and conference call to review the results at 4:30 p.m. Eastern Time on the same day [1] - The conference call can be accessed by U.S. investors at 877-407-6184 and international investors at 201-389-0877, with a conference ID of 13758446 [2] - A replay of the webcast will be available for approximately 30 days on the company's website following the event [2] Group 2 - MiMedx is a pioneer and leader in providing healing solutions, focusing on chronic and hard-to-heal wounds [3] - The company offers a leading portfolio of products for wound care, burn, and surgical sectors in healthcare [3] - MiMedx aims to be the leading global provider of healing solutions through relentless innovation to restore quality of life [3]

Company Overview - MiMedx Group, Inc. is a pioneer in the healthcare sector, focusing on healing solutions for chronic and hard-to-heal wounds [3] - The company has over a decade of experience in providing products for wound care, burn, and surgical applications [3] - MiMedx aims to be the leading global provider of healing solutions through continuous innovation [3] Event Participation - MiMedx's senior management will participate in the BofA Securities 2025 Healthcare Conference in Las Vegas, NV [1] - The presentation is scheduled for May 13, 2025, at 5:15 p.m. PDT [2] - Investors interested in meeting with senior management can contact their Bank of America representative [2]